Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emixustat in Geographic Atrophy (SEATTLE)
NCT01802866Phase 3Completed
- Sponsor
- Kubota Vision
- Start
- Feb 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of emixustat in geographic atrophy (GA), sponsored by Kubota Vision. Started Feb 2013; status: completed.
02
Drugs
emixustat
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01802866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802866.